Citations (87)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (23)
Sophie Vieujean, Edouard Louis, Silvio Danese & Laurent Peyrin-Biroulet. (2023) A critical review of ustekinumab for the treatment of active ulcerative colitis in adults. Expert Review of Gastroenterology & Hepatology 17:5, pages 413-430.
Read now
Read now
Charlotte W. Appel, Sarah Christine Pedersen, Amalie Søgaard Nielsen & Birgit Furstrand Larsen. (2022) Telemedicine based on patient-reported outcomes in management of patients with inflammatory bowel disease in a real-life setting – a before and after cohort study. Scandinavian Journal of Gastroenterology 57:7, pages 825-831.
Read now
Read now
Palle Bager, Christian Lodberg Hvas, Charlotte Lock Rud & Jens Frederik Dahlerup. (2022) Long-term maintenance treatment with 300 mg thiamine for fatigue in patients with inflammatory bowel disease: results from an open-label extension of the TARIF study. Scandinavian Journal of Gastroenterology 57:1, pages 37-43.
Read now
Read now
Susanna Walter, Michael P. Jones, Jenny Sjödahl, Henrik Stjernman, Henrik Hjortswang & Anna Andreasson. (2021) Measuring the impact of gastrointestinal inconvenience and symptoms on perceived health in the general population – validation of the Short Health Scale for gastrointestinal symptoms (SHS-GI). Scandinavian Journal of Gastroenterology 56:12, pages 1406-1413.
Read now
Read now
Carl Eriksson, Isabella Visuri, Lina Vigren, Linda Nilsson, Anders Kärnell, Henrik Hjortswang, Daniel Bergemalm, Sven Almer, Erik Hertervig, Per Karlén, Hans Strid & Jonas Halfvarson. (2021) Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG. Scandinavian Journal of Gastroenterology 56:11, pages 1304-1311.
Read now
Read now
Savanne Holster, Julia Rode, Johan Bohr, Ashok Kumar Kumawat, Gábor Veress, Elisabeth Hultgren Hörnquist, Robert Jan Brummer & Julia König. (2020) Faecal microbiota transfer in patients with microscopic colitis – a pilot study in collagenous colitis. Scandinavian Journal of Gastroenterology 55:12, pages 1454-1466.
Read now
Read now
Bjørn Rasmussen, Peter Haastrup, Sonja Wehberg, Jens Kjeldsen & Frans Boch Waldorff. (2020) Predictors of health-related quality of life in patients with moderate to severely active ulcerative colitis receiving biological therapy. Scandinavian Journal of Gastroenterology 55:6, pages 656-663.
Read now
Read now
Akter Hossain, Mikael Lördal, Annika E. Olsson, Anette Storlåhls, Soo Aleman, Michael Eberhardson & Ragnar Befrits. (2020) Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 55:2, pages 178-183.
Read now
Read now
Jonas F. Ludvigsson, Marie Andersson, Jonas Bengtsson, Michael Eberhardson, Ulrika L. Fagerberg, Olof Grip, Jonas Halfvarson, Henrik Hjortswang, Susanna Jäghult, Pontus Karling, Caroline Nordenvall, Ola Olén, Malin Olsson, Martin Rejler, Hans Strid & Pär Myrelid. (2019) Swedish Inflammatory Bowel Disease Register (SWIBREG) – a nationwide quality register. Scandinavian Journal of Gastroenterology 54:9, pages 1089-1101.
Read now
Read now
Sofie Coenen, Ellen Weyts, Patricia Geens, Séverine Vermeire, Marc Ferrante, Kris Vanhaecht & Gert Van Assche. (2019) Short Health Scale: a valid and reliable measure of quality of life in Dutch speaking patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology 54:5, pages 592-596.
Read now
Read now
Lone Larsen, Michael Dam Jensen, Michael Due Larsen, Rasmus Gaardskær Nielsen, Niels Thorsgaard, Ida Vind, Signe Wildt & Jens Kjeldsen. (2016) The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease. Clinical Epidemiology 8, pages 607-612.
Read now
Read now
Marianne Kiszka-Kanowitz, Klaus Theede & Anette Mertz-Nielsen. (2016) Randomized clinical trial: a pilot study comparing efficacy of low-dose azathioprine and allopurinol to azathioprine on clinical outcomes in inflammatory bowel disease. Scandinavian Journal of Gastroenterology 51:12, pages 1470-1475.
Read now
Read now
Lone Larsen, Asbjørn Mohr Drewes, Jan Fallingborg, Bent Ascanius Jacobsen & Tine Jess. (2016) Touch screens as a tool in patient care in the IBD outpatient clinic. Scandinavian Journal of Gastroenterology 51:9, pages 1106-1110.
Read now
Read now
Anne Sofie Krogh Holdam, Palle Bager & Jens Frederik Dahlerup. (2016) Biological therapy increases the health-related quality of life in patients with inflammatory bowel disease in a clinical setting. Scandinavian Journal of Gastroenterology 51:6, pages 706-711.
Read now
Read now
Andreas Münch, Johan Bohr, Lina Vigren, Curt Tysk & Magnus Ström. (2013) Lack of effect of methotrexate in budesonide-refractory collagenous colitis. Clinical and Experimental Gastroenterology 6, pages 149-152.
Read now
Read now
Ragnar Befrits, Ola Wikman, Lars Blomquist, Henrik Hjortswang, Per Hammarlund, Antal Bajor, Daniel Klintman & Håkan Blom. (2013) Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scandinavian Journal of Gastroenterology 48:9, pages 1027-1032.
Read now
Read now
Denise Keegan, Edel McDermott, Kathryn Byrne, David Moloney, Glen A Doherty & Hugh E Mulcahy. (2013) Development, validation and clinical assessment of a short questionnaire to assess disease-related knowledge in inflammatory bowel disease patients. Scandinavian Journal of Gastroenterology 48:2, pages 183-188.
Read now
Read now
Martin Rejler, Jörgen Tholstrup, Boel Andersson-Gäre & Anna Spångéus. (2012) Low prevalence of anemia in inflammatory bowel disease: A population-based study in Sweden. Scandinavian Journal of Gastroenterology 47:8-9, pages 937-942.
Read now
Read now
Andreas Münch, Simone Ignatova & Magnus Ström. (2012) Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scandinavian Journal of Gastroenterology 47:1, pages 59-63.
Read now
Read now
Susanna Walter, Henrik Hjortswang, Katarina Holmgren & Olof Hallböök. (2011) Association between bowel symptoms, symptom severity, and quality of life in Swedish patients with fecal incontinence. Scandinavian Journal of Gastroenterology 46:1, pages 6-12.
Read now
Read now
Henrik Stjernman, Curt Tysk, Sven Almer, Magnus Ström & Henrik Hjortswang. (2010) Worries and concerns in a large unselected cohort of patients with Crohn's disease. Scandinavian Journal of Gastroenterology 45:6, pages 696-706.
Read now
Read now
Lucia Snoei, Ad van Bodegraven, Bas Oldenburg, Theo Stijnen & Ad A Kaptein. (2009) Prototype evaluation of a self-management Internet diary for patients with ulcerative colitis. Patient Preference and Adherence 3, pages 179-187.
Read now
Read now
Anders Kald, Kristian N. Juul, Henrik Hjortsvang & Rune I. Sjödahl. (2008) Quality of life is impaired in patients with peristomal bulging of a sigmoid colostomy. Scandinavian Journal of Gastroenterology 43:5, pages 627-633.
Read now
Read now
Articles from other publishers (64)
Axel Dignass, Wolfgang Stremmel, Marek Horyński, Oleksandr Poyda, Peter Armerding, Klaus Fellermann, Jost Langhorst, Tanja Kuehbacher, Peter Uebel, Juergen Stein, Gottfried Novacek, Elena Avalueva, Oleksandr Oliinyk, Peter Hasselblatt, Andrey Dorofeyev, Heidrun Heinemann, Ralph Mueller, Roland Greinwald & Walter Reinisch. (2023) Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials. Clinical Gastroenterology and Hepatology.
Crossref
Crossref
Lisa Schrader, Birgitte Brandstrup & Gunnar Olaison. (2023) Slowly cutting, loose seton ligature and staged fistulotomy for healing of idiopathic perianal fistula and influence on anal continence. Langenbeck's Archives of Surgery 408:1.
Crossref
Crossref
Sina Demmer, Nikolaus Kleindienst, Henrik Hjortswang, Philipp Thomann, Matthias Ebert, Wolfgang Reindl & Anne Thomann. (2023) Validation of the German version of the Short Health Scale – a brief, valid and reliable instrument to assess health-related quality of life in German-speaking patients with inflammatory bowel diseases. Zeitschrift für Gastroenterologie 61:09, pages 1207-1213.
Crossref
Crossref
Anton Risto, Caroline Nordenvall, Mohammed Deputy, Maria Hermanson, Ulrik Lindforss, Mattias Block, Omar Faiz & Pär Myrelid. (2023) Colectomy reconstruction for ulcerative colitis in Sweden and England: a multicenter prospective comparison between ileorectal anastomosis and ileal pouch-anal anastomosis after colectomy in patients with ulcerative colitis. (CRUISE-study). BMC Surgery 23:1.
Crossref
Crossref
Casper Steenholdt, Ruben Due Lorentsen, Pernille Nørgaard Petersen & Jørn Brynskov. (2023) Trajectories of health‐related quality of life and fatigue during vedolizumab therapy in inflammatory bowel disease. Journal of Gastroenterology and Hepatology 38:4, pages 574-583.
Crossref
Crossref
Lone Larsen, Anastasia Karachalia SandriJan FallingborgBent Ascanius JacobsenHenrik Albæk JacobsenMartin BøgstedAsbjørn Mohr DrewesTine Jess. (2023) Has the Incidence of Inflammatory Bowel Disease Peaked? Evidence From the Population-Based NorDIBD Cohort 1978–2020. American Journal of Gastroenterology 118:3, pages 501-510.
Crossref
Crossref
Amalie Søgaard Nielsen, Charlotte W. Appel, Birgit Furstrand Larsen, Lisa Hanna & Lars Kayser. (2022) Digital patient-reported outcomes in inflammatory bowel disease routine clinical practice: the clinician perspective. Journal of Patient-Reported Outcomes 6:1.
Crossref
Crossref
Joel Thunberg, Olle Björkqvist, Charlotte R. H. Hedin, Anders Forss, Charlotte Söderman, Daniel Bergemalm, Ola Olén, Henrik Hjortswang, Hans Strid, Jonas F. Ludvigsson, Carl Eriksson & Jonas Halfvarson. (2022) Ustekinumab treatment in ulcerative colitis: Real‐world data from the Swedish inflammatory bowel disease quality register. United European Gastroenterology Journal 10:7, pages 631-639.
Crossref
Crossref
Jiang-tao HouBin PengShi-jing ZhangYong-xin LuoYi-ming ChenJia-zhong CaiYi WenHong MiJian-feng LuoXiao-mei ZhengSi-min PanShi-ying Liu, Xin-lin ChenBin Chen. (2022) The Short Health Scale: A Valid and Reliable Quality-of-Life Scale for Mainland Chinese Patients with Inflammatory Bowel Disease. Palliative Medicine Reports 3:1, pages 154-161.
Crossref
Crossref
Weiwei Dai, Yufeng Zeng, E. Liang, Qiuhong Zhou, Lei Zhang & Jie Peng. (2021) The actuality of resilience, social support and quality of life among patients with inflammatory bowel disease in China. Nursing Open 9:4, pages 2190-2198.
Crossref
Crossref
Wolfgang Kruis, Britta Siegmund, Konrad Lesniakowski, Vladimir Simanenkov, Ludmila Khimion, Marcin Sobon, Glebs Delmans, Svetlana V Maksyashina, Oleg A Sablin, Juris Pokrotnieks, Yuriy Mostovoy, Olena Datsenko, Sayar Abdulkhakov, Andriy Dorofeyev, Olena Levchenko, Olga Alexeeva, Pavel Andreev, Ivan P Kolesnik, Emese Mihaly, Orest Abrahamovych, Malgorzata Baluta, Nataliia Kharchenko, Neshta Viacheslav, Yury Uspenskiy, Michael Vieth, Ralf Mohrbacher, Ralph Mueller & Roland Greinwald. (2022) Novel Budesonide Suppository and Standard Budesonide Rectal Foam Induce High Rates of Clinical Remission and Mucosal Healing in Active Ulcerative Proctitis: a Randomised, Controlled, Non-inferiority Trial. Journal of Crohn's and Colitis.
Crossref
Crossref
Viktoria Bergqvist, Johanna Holmgren, Daniel Klintman & Jan Marsal. (2022) Real‐world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 55:11, pages 1389-1401.
Crossref
Crossref
Marianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, Jacob Tveiten Bjerrum, Jørn Brynskov, Ida Benedikte Gottschalck, Elena Akimenko, Karen Lisa Hilsted, Anders Neumann, Signe Wildt, Lone Larsen, Jens Kristian Munk, Per Holger Ibsen, Huma Gul Rehana Janjua, Lise Lotte Gluud & Anette Mertz-Nielsen. (2022) Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial. eClinicalMedicine 45, pages 101332.
Crossref
Crossref
Kristin E. Burke, Mauro D’Amato, Siew C. Ng, Darrell S. Pardi, Jonas F. Ludvigsson & Hamed Khalili. (2021) Microscopic colitis. Nature Reviews Disease Primers 7:1.
Crossref
Crossref
Jane Fletcher, Sheldon C. Cooper & Amelia Swift. (2021) Patient-Reported Outcomes in Inflammatory Bowel Disease: A Measurement of Effect in Research and Clinical Care. Gastroenterology Insights 12:2, pages 225-237.
Crossref
Crossref
Emma Paulides, Inge Boukema, Christien Janneke van der Woude & Nanne K H de Boer. (2021) The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review. Inflammatory Bowel Diseases 27:5, pages 711-724.
Crossref
Crossref
Anton Risto, Olof Hallböök, Peter Andersson, Rune Sjödahl & Pär Myrelid. (2021) Long-term Follow-up, Patient Satisfaction, and Quality of Life for Patients With Kock’s Continent Ileostomy. Diseases of the Colon & Rectum 64:4, pages 420-428.
Crossref
Crossref
Aleksandra Glapa-Nowak, Anna Bukowska-Posadzy, Mariusz Szczepanik, Jarosław Kwiecień, Anna Szaflarska-Popławska, Barbara Iwańczak, Anna Flak-Wancerz, Łukasz Dembiński, Marcin Osiecki, Jarosław Kierkuś, Tomasz Banasiewicz, Harald Walach, Aleksandra Banaszkiewicz & Jarosław Walkowiak. (2021) Subjective Psychophysical Experiences in the Course of Inflammatory Bowel Disease—A Comparative Analysis Based on the Polish Pediatric Crohn’s and Colitis Cohort (POCOCO). International Journal of Environmental Research and Public Health 18:2, pages 784.
Crossref
Crossref
Carl Eriksson, Sara Rundquist, Vyron Lykiardopoulos, Ruzan Udumyan, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Jenny Gunnarsson, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, David Öberg, Daniel Bergemalm, Henrik Hjortswang & Jonas Halfvarson. (2021) Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study. Therapeutic Advances in Gastroenterology 14, pages 175628482110233.
Crossref
Crossref
Yi-ming Chen, Jie-min Deng, Yi Wen, Bin Chen, Jiang-tao Hou, Bin Peng, Shi-jing Zhang, Hong Mi, Qi-long Jiang, Xia-lin Wu, Feng-bin Liu & Xin-lin Chen. (2020) Modified Sijunzi decoction in the treatment of ulcerative colitis in the remission phase: study protocol for a series of N-of-1 double-blind, randomised controlled trials. Trials 21:1.
Crossref
Crossref
J. Jin, W. Xia, A. Connolly & A.G. Hill. (2020) Symptom‐based scoring for haemorrhoidal disease: a systematic review. Colorectal Disease 22:11, pages 1518-1527.
Crossref
Crossref
Emma M van Andel, Brechtje D M Koopmann, Femke Crouwel, Casper G Noomen, Nanne K H de Boer, Dirk P van Asseldonk & Lidwine B Mokkink. (2020) Systematic Review of Development and Content Validity of Patient-reported Outcome Measures in Inflammatory Bowel Disease: Do We Measure What We Measure?. Journal of Crohn's and Colitis 14:9, pages 1299-1315.
Crossref
Crossref
Rikke Edelbo, Malte Hjerrild & Palle Bager. (2020) Impact of remission on worries experienced by patients receiving biologic therapy for inflammatory bowel disease. Gastrointestinal Nursing 18:7, pages 28-33.
Crossref
Crossref
Margareta Nyman, Thao Duy Nguyen, Ola Wikman, Henrik Hjortswang & Claes Hallert. (2020) Oat Bran Increased Fecal Butyrate and Prevented Gastrointestinal Symptoms in Patients With Quiescent Ulcerative Colitis—Randomized Controlled Trial. Crohn's & Colitis 360 2:1.
Crossref
Crossref
Maie Abdalla, Rickard Norblad, Malin Olsson, Kalle Landerholm, Peter Andersson, Johan D. Söderholm, Roland Andersson & Pär Myrelid. (2019) Anorectal Function After Ileo-Rectal Anastomosis Is Better than Pelvic Pouch in Selected Ulcerative Colitis Patients. Digestive Diseases and Sciences 65:1, pages 250-259.
Crossref
Crossref
Monica Wåhlin, Henrik Stjernman & Berit Munck. (2019) Disease-Related Worries in Persons With Crohn Disease. Gastroenterology Nursing 42:5, pages 435-442.
Crossref
Crossref
Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Michael Vieth, Ulrike von Arnim, Javier Molina-Infante, Dirk Hartmann, Albert Jan Bredenoord, Constanza Ciriza de los Rios, Stefan Schubert, Stefan Brückner, Ahmed Madisch, Jamal Hayat, Jan Tack, Stephen Attwood, Ralph Mueller, Roland Greinwald, Alain Schoepfer, Alex Straumann, Jan Tack, Tim Vanuytsel, Hubert Louis, Carmen Musala, Stephan Miehlke, Dorothea Frederking, Monther Bajbouj, Christoph Schlag, Simon Nennstiel, Stefan Brückner, Renate Schmelz, Schmelz Heimerl, Anna-Magdalena Stephan, Christiane Fibbe, Niels Liedtke (née Laschinsky)Jutta Keller, Ulrich Rosien, Sebastian Haag, Arne Schneider, Dirk Hartmann, Christoph Schmöcker, Hendrik Buchholz, Frank Lammert, Markus Casper, Matthias Reichert, Ahmed Madisch, Dirk Sommer, Hubert Mönnikes, Miriam Stengel, Marco Schmidtmann, Michaela Müller, Alexander Eckardt, Till Wehrmann, Stefan Schubert, Peter Armerding, Wolf Peter Hofmann, Thomas Liceni, Ulrike von Arnim, Arne Kandulski, Jochen Weigt, Norbert Börner, Anne Lutz-Vorderbrügge, Jörg Albert, Stefan Zeuzem, Irina Blumenstein, Kathrin Sprinzl, Johannes Hausmann, Arjan Bredenoord, Arjan Bredenoord, Marijn Warners, Alfredo Lucendo Villarin, Ángel Arias Arias, Maria Ángeles Tejero Bustos, María Jesús Carrillo Ramos, José María Olalla Gallardo, Rocío Juárez Tosina, Javier Molina-Infante, José Zamorano, Cecilio Santander Vaquero, Sergio Casabona Francés, Teresa Pérez, Teresa Rodriguez, Constanza Ciriza de los Ríos, Fernando Canga Rodríguez-Valcárcel, Isabel Castel de Lucas, Antonia Perelló Juan, Merce Barenys, Carlos Pons, Isabel Perez Martinez, M. Eugenia Lauret, Andrés Castaño García, Esmeralda Rubio, Alex Straumann, Petr Hruz, Simon Brunner, Jamal Hayat & Andrew Poullis. (2019) Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. Gastroenterology 157:1, pages 74-86.e15.
Crossref
Crossref
Håvard D. Rørvik, Karl Styr, Lars Ilum, Grant L. McKinstry, Tove Dragesund, André H. Campos, Birgitte Brandstrup & Gunnar Olaison. (2019) Hemorrhoidal Disease Symptom Score and Short Health ScaleHD: New Tools to Evaluate Symptoms and Health-Related Quality of Life in Hemorrhoidal Disease. Diseases of the Colon & Rectum 62:3, pages 333-342.
Crossref
Crossref
Brona Wynne, Louise McHugh, Wei Gao, Denise Keegan, Kathryn Byrne, Catherine Rowan, Karen Hartery, Clemens Kirschbaum, Glen Doherty, Garret Cullen, Barbara Dooley & Hugh E. Mulcahy. (2019) Acceptance and Commitment Therapy Reduces Psychological Stress in Patients With Inflammatory Bowel Diseases. Gastroenterology 156:4, pages 935-945.e1.
Crossref
Crossref
Axel Dignass, Robert Schnabel, Jacek Romatowski, Vladimir Pavlenko, Andrey Dorofeyev, Jelena Derova, Laimas Jonaitis, Karin Dilger, Tanju Nacak & Roland Greinwald. (2017) Efficacy and safety of a novel high-dose mesalazine tablet in mild to moderate active ulcerative colitis: a double-blind, multicentre, randomised trial. United European Gastroenterology Journal 6:1, pages 138-147.
Crossref
Crossref
Robin Christensen, Berit L Heitmann, Karina Winther Andersen, Ole Haagen Nielsen, Signe Bek Sørensen, Mohamad Jawhara, Anette Bygum, Lone Hvid, Jakob Grauslund, Jimmi Wied, Henning Glerup, Ulrich Fredberg, Jan Alexander Villadsen, Søren Geill Kjær, Jan Fallingborg, Seyed A G R Moghadd, Torben Knudsen, Jacob Brodersen, Jesper Frøjk, Jens Frederik Dahlerup, Anders Bo Bojesen, Grith Lykke Sorensen, Steffen Thiel, Nils J Færgeman, Ivan Brandslund, Tue Bjerg Bennike, Allan Stensballe, Erik Berg Schmidt, Andre Franke, David Ellinghaus, Philip Rosenstiel, Jeroen Raes, Mette Boye, Lars Werner, Charlotte Lindgaard Nielsen, Heidi Lausten Munk, Anders Bathum Nexøe, Torkell Ellingsen, Uffe Holmskov, Jens Kjeldsen & Vibeke Andersen. (2018) Impact of red and processed meat and fibre intake on treatment outcomes among patients with chronic inflammatory diseases: protocol for a prospective cohort study of prognostic factors and personalised medicine. BMJ Open 8:2, pages e018166.
Crossref
Crossref
Aaron Yarlas, Martha Bayliss, Joseph C. Cappelleri, Stephen Maher, Andrew G. Bushmakin, Lea Ann Chen, Alireza Manuchehri & Paul Healey. (2017) Psychometric validation of the SF-36® Health Survey in ulcerative colitis: results from a systematic literature review. Quality of Life Research 27:2, pages 273-290.
Crossref
Crossref
Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin, Leif Angelison, Per Hammarlund, Marie Olin, Jörgen Torp, Olof Grip, Stefan Nilson, Erik Hertervig, Jan Lillienau & Jan Marsal. (2018) Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease. Therapeutic Advances in Gastroenterology 11, pages 175628481880124.
Crossref
Crossref
Xin-Lin Chen, Liang-huan Zhong, Yi Wen, Tian-Wen Liu, Xiao-Ying Li, Zheng-Kun Hou, Yue Hu, Chuan-wei Mo & Feng-Bin Liu. (2017) Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health and Quality of Life Outcomes 15:1.
Crossref
Crossref
Soo-Kyung Park, Bong Min Ko, Hyeon Jeong Goong, Jeong Yeon Seo, Sang Hyuk Lee, Hae Lim Baek, Moon Sung Lee & Dong Il Park. (2017) Short health scale: A valid measure of health-related quality of life in Korean-speaking patients with inflammatory bowel disease. World Journal of Gastroenterology 23:19, pages 3530.
Crossref
Crossref
Edel Berroa de la Rosa, Natalia Mora Cuadrado & Luis Fernández Salazar. (2017) The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire. Revista Española de Enfermedades Digestivas 109.
Crossref
Crossref
Katrine Carlsen, Pia Munkholm & Johan Burisch. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
279
289
.
Axel Dignass, Ayesha Akbar, Ailsa Hart, Sreedhar Subramanian, Gilles Bommelaer, Daniel C. Baumgart, Jean-Charles Grimaud, Guillaume Cadiot, Richard Makins, Syed Hoque, Guillaume Bouguen & Bruno Bonaz. (2016) Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results. Journal of Crohn's and Colitis 10:7, pages 812-820.
Crossref
Crossref
Christian L. Hvas, Anders Dige, Mia Bendix, Pernille G. Wernlund, Lisbet A. Christensen, Jens F. Dahlerup & Jørgen Agnholt. (2016) Casein glycomacropeptide for active distal ulcerative colitis: a randomized pilot study. European Journal of Clinical Investigation 46:6, pages 555-563.
Crossref
Crossref
Katarina Pihl Lesnovska, Gunilla Hollman Frisman, Henrik Hjortswang & Sussanne Börjeson. (2016) Critical Situations in Daily Life as Experienced by Patients With Inflammatory Bowel Disease. Gastroenterology Nursing 39:3, pages 195-203.
Crossref
Crossref
Andreas Münch, Johan Bohr, Stephan Miehlke, Cecilia Benoni, Martin Olesen, Åke Öst, Lars Strandberg, Per M Hellström, Erik Hertervig, Peter Armerding, Jiri Stehlik, Greger Lindberg, Jan Björk, Annika Lapidus, Robert Löfberg, Ole Bonderup, Sören Avnström, Martin Rössle, Karin Dilger, Ralph Mueller, Roland Greinwald, Curt Tysk & Magnus Ström. (2016) Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut 65:1, pages 47-56.
Crossref
Crossref
Denise Keegan, Kathryn Byrne, Garret Cullen, Glen A. Doherty, Barbara Dooley & Hugh E. Mulcahy. (2015) The Stressometer: A Simple, Valid, and Responsive Measure of Psychological Stress in Inflammatory Bowel Disease Patients. Journal of Crohn's and Colitis 9:10, pages 881-885.
Crossref
Crossref
Anne L. Krarup, Emma Peterson, Gisela Ringström, Hans Törnblom, Henrik Hjortswang & Magnus Simrén. (2015) The Short Health Scale. Journal of Clinical Gastroenterology 49:7, pages 565-570.
Crossref
Crossref
Klaus Theede, Marianne Kiszka-Kanowitz, Inge Nordgaard-Lassen & Anette Mertz Nielsen. (2015) The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients. Journal of Crohn's and Colitis 9:8, pages 625-632.
Crossref
Crossref
Slaven Abdovic, Ana Mocic Pavic, Milan Milosevic, Mladen Persic, Irena Senecic-Cala & Sanja Kolacek. (2015) Short Health Scale. Inflammatory Bowel Diseases 21:4, pages 818-823.
Crossref
Crossref
Anders Lasson, Lena Öhman, Per-Ove Stotzer, Stefan Isaksson, Otto Überbacher, Kjell-Arne Ung & Hans Strid. (2015) Pharmacological intervention based on fecal calprotectin levels in patients with ulcerative colitis at high risk of a relapse: A prospective, randomized, controlled study. United European Gastroenterology Journal 3:1, pages 72-79.
Crossref
Crossref
L. Emilsson, B. Lindahl, M. Köster, M. Lambe & J. F. Ludvigsson. (2015) Review of 103 Swedish Healthcare Quality Registries. Journal of Internal Medicine 277:1, pages 94-136.
Crossref
Crossref
Axel Dignass, Simeon Stoynov, Andrey E. Dorofeyev, Galina A. Grigorieva, Eva Tomsová, István Altorjay, Daniel Tuculanu, Ivan Bunganič, Juris Pokrotnieks, Limas Kupčinskas, Karin Dilger, Roland Greinwald & Ralph Mueller. (2014) Once versus three times daily dosing of oral budesonide for active Crohn's disease: A double-blind, double-dummy, randomised trial. Journal of Crohn's and Colitis 8:9, pages 970-980.
Crossref
Crossref
N. Nyhlin, A. Wickbom, S. M. Montgomery, C. Tysk & J. Bohr. (2014) Long‐term prognosis of clinical symptoms and health‐related quality of life in microscopic colitis: a case–control study. Alimentary Pharmacology & Therapeutics 39:9, pages 963-972.
Crossref
Crossref
Irina Blumenstein, Edel McDermott, Denise Keegan, Kathryn Byrne, Martha Ellison, Glen Doherty, Oliver Schröder & Hugh Mulcahy. (2013) Sources of information and factual knowledge in Europeans with inflammatory bowel diseases: A cross-cultural comparison between German and Irish patients. Journal of Crohn's and Colitis 7:9, pages e331-e336.
Crossref
Crossref
Edel McDermott, Denise Keegan, Kathryn Byrne, Glen A. Doherty & Hugh E. Mulcahy. (2013) The Short Health Scale: A valid and reliable measure of health related quality of life in English speaking inflammatory bowel disease patients. Journal of Crohn's and Colitis 7:8, pages 616-621.
Crossref
Crossref
Nienke Lesuis, Ragnar Befrits, Filippa Nyberg & Ronald F van Vollenhoven. (2012) Gender and the treatment of immune-mediated chronic inflammatory diseases: rheumatoid arthritis, inflammatory bowel disease and psoriasis: an observational study. BMC Medicine 10:1.
Crossref
Crossref
Lars-Petter Jelsness-Jørgensen, Tomm Bernklev & Bjørn Moum. (2011) Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the Short Health Scale (SHS). Quality of Life Research 21:9, pages 1671-1676.
Crossref
Crossref
R. Sjödahl, C. Schulz, P. Myrelid & P. Andersson. (2012) Long‐term quality of life in patients with permanent sigmoid colostomy. Colorectal Disease 14:6.
Crossref
Crossref
Pia Munkholm & Natalia Pedersen. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
333
340
.
Annelie Lindberg, Michael Eberhardson, Mats Karlsson & Per Karlén. (2010) Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease. BMC Gastroenterology 10:1.
Crossref
Crossref
Dawn Farrell & Eileen Savage. (2010) Symptom burden in inflammatory bowel disease: Rethinking conceptual and theoretical underpinnings. International Journal of Nursing Practice 16:5, pages 437-442.
Crossref
Crossref
G. R. Lichtenstein, G. L. Gordon, S. Zakko, U. Murthy, S. Sedghi, R. Pruitt, K. Merchant, A. Shaw, E. Bortey & W. P. Forbes. (2010) Clinical trial: once‐daily mesalamine granules for maintenance of remission of ulcerative colitis – a 6‐month placebo‐controlled trial. Alimentary Pharmacology & Therapeutics 32:8, pages 990-999.
Crossref
Crossref
A. Gustavsson, G. Järnerot, E. Hertervig, I. Friis‐Liby, L. Blomquist, P. Karlén, C. Grännö, M. Vilien, M. Ström, H. Verbaan, P. M. Hellström, A. Magnuson, J. Halfvarson & C. Tysk. (2010) Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab study. Alimentary Pharmacology & Therapeutics 32:8, pages 984-989.
Crossref
Crossref
Henrik Hjortswang, Curt Tysk, Johan Bohr, Cecilia Benoni, Anders Kilander, Lasse Larsson, Lina Vigren & Magnus Ström. (2009) Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflammatory Bowel Diseases 15:12, pages 1875-1881.
Crossref
Crossref
Maria H. Lönnkvist, Ragnar Befrits, Jon O. Lundberg, Joachim Lundahl, Ulrika L. Fagerberg, Henrik Hjortswang, Marianne van Hage & Per M. Hellström. (2009) Infliximab in clinical routine: experience with Crohnʼs disease and biomarkers of inflammation over 5 years. European Journal of Gastroenterology & Hepatology 21:10, pages 1168-1176.
Crossref
Crossref
A Koch, S Bringman, P Myrelid, S Smeds & A Kald. (2008) Randomized clinical trial of groin hernia repair with titanium-coated lightweight mesh compared with standard polypropylene mesh. British Journal of Surgery 95:10, pages 1226-1231.
Crossref
Crossref
Kjerstin Larsson, Lars Lööf, Anders Rönnblom & Karin Nordin. (2008) Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. Journal of Psychosomatic Research 64:2, pages 139-148.
Crossref
Crossref
Henrik Stjernman, Christer Grännö, Gunnar Järnerot, Leif Ockander, Curt Tysk, Björn Blomberg, Magnus Ström & Henrik Hjortswang. (2008) Short health scale: A valid, reliable, and responsive instrument for subjective health assessment in Crohnʼs disease. Inflammatory Bowel Diseases 14:1, pages 47-52.
Crossref
Crossref